Study of Medicine Stick Therapy Combined With Repeated Urotong Herapy on Lower Limb Dysfunction in Stroke Patients
Launched by JIANGEN YE · Aug 5, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people recover movement in their legs after a stroke. It will look at how well a treatment called medicine stick therapy works on its own, and how it works when combined with repetitive facial exercises (RFE). The researchers want to see if these treatments can improve leg movement, balance, daily activities, and overall quality of life in stroke patients.
The study is open to adults who have had their first stroke within the last three months. People with serious other health problems, trouble thinking clearly, or skin issues where the treatment would be applied cannot join. Participants will receive one or both treatments, and the researchers will follow their progress over time to see how well they recover. This study hasn’t started recruiting yet, but it aims to provide helpful information on better ways to support stroke recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of stroke
- • The first onset and the disease duration must be less than 3 months. exclusion criteria:
- • Combined with other serious diseases such as severe cardiovascular, respiratory failure, liver and renal function damage, malignant tumors, etc.
- • Consciousness disorders and cognitive impairment;
- • Eczema, inflammation, infection, and scars at acupuncture points or skin;
About Jiangen Ye
Jiangen Ye is a clinical trial sponsor engaged in advancing medical research through the design and oversight of clinical studies. With a commitment to scientific rigor and ethical standards, Jiangen Ye focuses on contributing to the development of innovative therapies and improving patient outcomes across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported